These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 2228343

  • 1. Ranitidine in children with peptic ulcer and patients with pancreatic cystic fibrosis.
    Scorza A, Conti-Nibali S, Sferlazzas C, Saitta G, Tedeschi A.
    Int J Clin Pharmacol Res; 1990; 10(3):179-82. PubMed ID: 2228343
    [Abstract] [Full Text] [Related]

  • 2. Frequency, consequences and pharmacological treatment of gastroesophageal reflux in children with cystic fibrosis.
    Brodzicki J, Trawińska-Bartnicka M, Korzon M.
    Med Sci Monit; 2002 Jul; 8(7):CR529-37. PubMed ID: 12118204
    [Abstract] [Full Text] [Related]

  • 3. Do H2 receptor antagonists have a therapeutic role in childhood?
    Kelly DA.
    J Pediatr Gastroenterol Nutr; 1994 Oct; 19(3):270-6. PubMed ID: 7815256
    [Abstract] [Full Text] [Related]

  • 4. [Ranitidine VUFB in the treatment of peptic ulcer].
    Steinigerová J, Kratochvíl J.
    Vnitr Lek; 1991 Feb; 37(2):135-40. PubMed ID: 2021072
    [Abstract] [Full Text] [Related]

  • 5. Oral ranitidine and duration of gastric pH >4.0 in infants with persisting reflux symptoms.
    Salvatore S, Hauser B, Salvatoni A, Vandenplas Y.
    Acta Paediatr; 2006 Feb; 95(2):176-81. PubMed ID: 16449023
    [Abstract] [Full Text] [Related]

  • 6. Effect of acid inhibition on Campylobacter pylori.
    Blanco M, Pajares JM, Jimenez ML, Lopez-Brea M.
    Scand J Gastroenterol Suppl; 1988 Feb; 142():107-9. PubMed ID: 2901784
    [Abstract] [Full Text] [Related]

  • 7. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
    Pfefferkorn MD, Croffie JM, Gupta SK, Molleston JP, Eckert GJ, Corkins MR, Fitzgerald JF.
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
    [Abstract] [Full Text] [Related]

  • 8. Drug therapy of peptic ulcer disease.
    Ching CK, Lam SK.
    Br J Hosp Med; 2006 Feb; 54(2-3):101-6. PubMed ID: 7551483
    [Abstract] [Full Text] [Related]

  • 9. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB, Cirillo P, Roggero P, Romano C, Malamisura B, Terrin G, Passariello A, Manguso F, Morelli L, Guarino A, Working Group on Intestinal Infections of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP).
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [Abstract] [Full Text] [Related]

  • 10. Use of H2-receptor antagonists in children.
    Dimand RJ.
    DICP; 1990 Nov; 24(11 Suppl):S42-6. PubMed ID: 2270695
    [Abstract] [Full Text] [Related]

  • 11. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
    Campbell DR, Haber MM, Sheldon E, Collis C, Lukasik N, Huang B, Goldstein JL.
    Am J Gastroenterol; 2002 Sep; 97(9):2208-14. PubMed ID: 12358234
    [Abstract] [Full Text] [Related]

  • 12. Ranitidine: a new H2-receptor antagonist.
    Zeldis JB, Friedman LS, Isselbacher KJ.
    N Engl J Med; 1983 Dec 01; 309(22):1368-73. PubMed ID: 6314139
    [No Abstract] [Full Text] [Related]

  • 13. [Primary peptic ulcer in infancy and childhood. Personal experience].
    Lama Moré R, Prieto Bozano G, Carrasco Gandía S, Miralles Adarraga T, Polanco Allúe I.
    An Esp Pediatr; 1990 Aug 01; 33(2):113-6. PubMed ID: 2275489
    [Abstract] [Full Text] [Related]

  • 14. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
    Rodríguez Hernández H, Sánchez Anguiano LF, Quiñones E.
    Rev Gastroenterol Mex; 1998 Aug 01; 63(1):21-7. PubMed ID: 10068745
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of acid-related diseases of the gastrointestinal tract. Observations in patients receiving a single evening dose of 300 mg ranitidine].
    Sewing KF, Franz E.
    Fortschr Med; 1992 Mar 10; 110(7):114-6. PubMed ID: 1559647
    [Abstract] [Full Text] [Related]

  • 16. Helicobacter pylori infection in childhood: results of management with ranitidine bismuth citrate plus amoxicillin and tinidazole.
    Nijevitch AA, Farztdinov KM, Sataev VU, Khasanov RSh, Katayev VA, Khusnutdinov SM, Akhunov ED, Kazykhanov NS.
    J Gastroenterol Hepatol; 2000 Nov 10; 15(11):1243-50. PubMed ID: 11129216
    [Abstract] [Full Text] [Related]

  • 17. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
    Tam YH, Yeung CK, Lee KH.
    Aliment Pharmacol Ther; 2006 Jul 01; 24(1):81-6. PubMed ID: 16803605
    [Abstract] [Full Text] [Related]

  • 18. Drug therapy for peptic ulcer disease.
    Voirin J.
    Am Fam Physician; 1984 Dec 01; 30(6):154-9. PubMed ID: 6095630
    [No Abstract] [Full Text] [Related]

  • 19. Ranitidine: a pilot study in Japan.
    Takemoto T, Okazaki Y, Okita K, Namiki M, Ishikawa M, Oshiba S, Kurokawa K.
    Scand J Gastroenterol Suppl; 1981 Jun 01; 69():125-8. PubMed ID: 6119776
    [Abstract] [Full Text] [Related]

  • 20. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U, Raps S, Plein K, Leodolter A, Hotz Dagger J, Malfertheiner P.
    Dtsch Med Wochenschr; 2004 Mar 26; 129(13):671-5. PubMed ID: 15026962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.